Pharmacies in the UK report that 75mg immediate-release (IR) venlafaxine tablets are out of stock and will remain unavailable until November, according to reporting by the Daily Mail/Mail Online.
Venlafaxine is prescribed for conditions including depression and anxiety, and it is also used in some cases for symptoms such as those related to menopause. The outlets describe the shortage as affecting specific tablet packs of 75mg IR, without detailing the underlying cause or whether alternative strengths or formulations remain available.
The coverage focuses primarily on the disruption to access for patients who rely on that particular product size and release type, rather than providing broader national shortage statistics or guidance on substitutions. Neither outlet offers additional context on supply chain issues, regulatory steps, or expected timelines beyond the stated “until November” timeframe.
